Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Cervical Cancer

Treatments: Other: Testing of archived cervical cancer tissue samples; Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01328028

111050

Details and patient eligibility

About

The aim of this study is to assess the distribution of the most frequent types of human papillomavirus in women diagnosed with invasive cervical cancer in New Zealand.

Enrollment: 244 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A female aged 18 years and above at the time of cervical specimen collection, and currently residing in New Zealand.
• Histological diagnoses of invasive cervical cancer stage IB or greater, within at least the last 3 years.
• Written informed consent obtained from the subject/ next of kin/ Legally acceptable representative.
• Availability of cervical specimen on which the diagnosis was made prior to any chemotherapy or radiotherapy.
• The cervical specimen should be of appropriate size and with regular tissue specimens.
• The cervical specimen should be adequately preserved.
• All links to the subject's identity should be removed from the paraffin block.

Exclusion criteria

Not Applicable.

Trial design

244 participants in 1 patient group

Group A

Description:

Subjects diagnosed with invasive cervical cancer

Treatment:

Other: Testing of archived cervical cancer tissue samples

Other: Data collection